EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis

Amanda Kiemes iD, Nicholas R Livingston iD, Paulina B Lukow iD, Samuel Knight iD, Luke Jelen iD, Thomas Reilly iD, Aikaterini Dima iD, Maria A Nettis iD, David J Lythgoe iD, Cecilia Casetta iD, Alice Egerton iD, Thomas Spencer iD und 8 weitere

International Journal of Neuropsychopharmacology · 2026

DOI: 10.1093/ijnp/pyaf078 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Neuropsychopharmacology, 2026. Verfasst von Amanda Kiemes und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. Hauptthemen laut MEDLINE: Gyrus Cinguli, Diazepam, Psychotic Disorders, Glutamic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR, Department of Health and Social Care, Wellcome Trust and the Royal Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Preclinical evidence suggests that modulating neural excitation through administration of diazepam, a positive allosteric modulator of GABAA receptors, can prevent the emergence of behavioral and neurobiological alterations relevant to psychosis in adulthood. Design and Participants Here, we examine this neurochemical mechanism in individuals at clinical high risk for psychosis in a randomized, double-blind, placebo-controlled crossover study. Twenty-four individuals (15 female and 9 male) aged 18-35 were scanned twice using proton magnetic resonance spectroscopy to measure anterior cingulate cortex Glx (glutamate and glutamine) levels, once after a single dose of diazepam (5 mg) and once after placebo.

Results

Mixed-effects model analyses revealed that diazepam reduced anterior cingulate cortex Glx levels compared to placebo (t(20.8) = −2.14, P = .04). The effect of diazepam on Glx levels was greater in older individuals at clinical high risk for psychosis (t(12) = −4.36, P = .001).

Conclusion

These findings suggest that pharmacological modulation of GABAA receptors can alter Glx changes in and support a novel therapeutic mechanism of benefit for individuals at clinical high risk of psychosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gyrus CinguliDiazepamPsychotic DisordersGlutamic AcidGABA ModulatorsHumansFemaleMaleAdultDouble-Blind MethodYoung AdultCross-Over StudiesAdolescentMagnetic Resonance Spectroscopy

Stichwörter der Autor:innen

Glxbenzodiazepinesclinical high risk for psychosismagnetic resonance spectroscopyschizophrenia

Substanzen

DiazepamGlutamic AcidGABA Modulators

Autor:innen und Institutionen

  • Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Institute of Cognitive Neuroscience, University College London, London, United Kingdom.
  • Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • South London and Maudsley NHS Foundation Trust, London, United Kingdom.
  • Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

ORCID-Profile: Amanda Kiemes, Nicholas R Livingston, Paulina B Lukow, Samuel Knight, Luke Jelen, Thomas Reilly, Aikaterini Dima, Maria A Nettis, David J Lythgoe, Cecilia Casetta, Alice Egerton, Thomas Spencer, Andrea De Micheli, Paolo Fusar-Poli, Anthony A Grace, Steven C R Williams, Philip McGuire, Cathy Davies, James M Stone, Gemma Modinos

Förderung

  • NIHR
  • Department of Health and Social Care
  • Wellcome Trust and the Royal Society
  • NIMH NIH HHS
  • Maudsley Biomedical Research Centre
  • National Institute for Health and Care Research
  • Wellcome Trust

Zitieren

APA

Kiemes, A., Livingston, N. R., Lukow, P. B., Knight, S., Jelen, L., Reilly, T., Dima, A., Nettis, M. A., Lythgoe, D. J., Casetta, C., Egerton, A., Spencer, T., De Micheli, A., Fusar-Poli, P., Grace, A. A., Williams, S. C. R., McGuire, P., Davies, C., Stone, J. M., & Modinos, G. (2026). Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaf078

Vancouver

Kiemes A, Livingston NR, Lukow PB, Knight S, Jelen L, Reilly T, et al. Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis. International Journal of Neuropsychopharmacology. 2026. doi:10.1093/ijnp/pyaf078

BibTeX
@article{Kiemes2026,
  author = {Kiemes, Amanda and Livingston, Nicholas R and Lukow, Paulina B and Knight, Samuel and Jelen, Luke and Reilly, Thomas and Dima, Aikaterini and Nettis, Maria A and Lythgoe, David J and Casetta, Cecilia and Egerton, Alice and Spencer, Thomas and De Micheli, Andrea and Fusar-Poli, Paolo and Grace, Anthony A and Williams, Steven C R and McGuire, Philip and Davies, Cathy and Stone, James M and Modinos, Gemma},
  title = {Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2026},
  doi = {10.1093/ijnp/pyaf078}
}
Kostenlos starten →